Asia-Pacific Biotechnology Market Surging Ahead with a 19% Growth
The Asia-Pacific biotechnology market is likely to grow at a CAGR of around 19% during 2010-2013, acknowledged RNCOS.

Our research identified that Japan has been dominating the Asia-Pacific Biotechnology market but the industry has undergone several setbacks due to economic slowdown. As a result, opportunities in other economies, such as China, India, Singapore, and Australia were explored which have shown positive growth in recent times. It is however, expected that the biotechnology sector in the Asia-Pacific region will be governed by these countries in future. Other highly promising areas in the Asia Pacific have been the regions of South Korea, Taiwan, and Malaysia, which have posted a double digit growth and are expected to continue this trend in the future as well. Thus, Asia-Pacific biotechnology market is projected to grow at a CAGR 19% between 2010 and 2013.
The Asia-Pacific biotechnology market has become a highly lucrative option for development as it offers low labor costs and a very large pool of human resource at the same time. Also, the biotechnology infrastructure and education too is of ace quality here. Thus, this region is highly benefiting for foreign companies to set up their base and several multinationals have already setup their production and research facilities in the Asia-Pacific region. Clinical trials and contract manufacturing have shown particular growth in these regions. Amongst several biotechnology sectors in the market, biosimilars, agricultural biotechnology, and industrial biotechnology are expected to surge to the highest.
The report "Asia Pacific Biotechnology Market (2008-2012)", analyses the biotechnology market in the region and provides detailed product and geographical segmentation to the reader. Current and future forecasts have been provided to the reader for a comprehensive analysis. Further key trends in the market have been identified along with the emerging opportunity areas that help the clients in making informed decisions for investments in the sector. Government regulations have also been covered to present an overall picture of the regulatory environment. The report provides a holistic approach to the reader to analyze the opportunities that the Asia-Pacific Biotechnology market has to offer.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM138.htm
Some of our Related Reports are:
- US Biotech Market Analysis (http://www.rncos.com/Report/IM0300.htm)
- Global miRNA Market Outlook (http://www.rncos.com/Report/IM286.htm)
- Global HIV Therapeutics Market Analysis (http://www.rncos.com/Report/IM361.htm)
- Booming Biotech Market in India (http://www.rncos.com/Report/IM110.htm)
- Global Gene Therapy Market Analysis (http://www.rncos.com/Report/IM282.htm)
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
About RNCOS
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.
###
Tag Words:
vaccine, biosimilars
Categories: Technology
Press Release Contact
B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707
B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707